Ginkgo Bioworks Holdings, Inc. (DNA)
NYSE: DNA · Real-Time Price · USD
8.85
-0.49 (-5.25%)
At close: Jul 8, 2026, 4:00 PM EDT
9.07
+0.22 (2.49%)
After-hours: Jul 8, 2026, 6:30 PM EDT
Ginkgo Bioworks Holdings Market Cap
Ginkgo Bioworks Holdings has a market cap or net worth of $578.12 million as of July 8, 2026. Its market cap has increased by 15.79% in one year.
Market Cap
578.12M
Enterprise Value
615.37M
1-Year Change
15.79%
Ranking
Category
Stock Price
$8.85
Market Cap Chart
Since April 19, 2021, Ginkgo Bioworks Holdings's market cap has decreased from $2.18B to $578.12M, a decrease of -73.51%. That is a compound annual growth rate of -22.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 8, 2026 | 578.12M | 22.40% |
| Dec 31, 2025 | 472.31M | -9.39% |
| Dec 31, 2024 | 521.27M | -84.36% |
| Dec 29, 2023 | 3.33B | 16.75% |
| Dec 30, 2022 | 2.86B | -76.89% |
| Dec 31, 2021 | 12.35B | 466.18% |
| Apr 19, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Gyre Therapeutics | 640.52M |
| Bright Minds Biosciences | 639.81M |
| Monopar Therapeutics | 637.86M |
| Eikon Therapeutics | 628.01M |
| MiMedx Group | 625.57M |
| Nuvectis Pharma | 605.29M |
| ProKidney | 589.02M |
| Kyverna Therapeutics | 588.50M |